Stock Track | Galapagos NV Plunges 8% After Q2 Earnings Miss and Widened Losses

Stock Track07-24

Shares of Galapagos NV (GLPG) tumbled 8.02% in Thursday's trading session following the release of its disappointing second-quarter 2025 financial results. The biotechnology company reported a significant loss that fell well short of analyst expectations, causing investor concern.

Galapagos posted a quarterly adjusted loss of €1.60 per share for the quarter ended June 30, a stark contrast to the €0.14 earnings per share reported in the same quarter last year. This result significantly missed the mean expectation of six analysts, who had forecast a loss of €0.20 per share. Revenue also declined by 16.2% to €65.29 million, falling short of the €70.60 million analysts had anticipated.

The company's financial struggles were further highlighted in its half-year results, with Galapagos reporting a loss of €3.93 per diluted share for the first six months of 2025, compared to a profit of €1.51 per share in the same period last year. Despite these challenges, half-year revenue remained unchanged at €140.3 million. The stark reversal in profitability and the revenue decline in Q2 have raised concerns about the company's near-term prospects, leading to the sharp sell-off in its stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104428000?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-24 15:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104428000","market":"nz","top_or_hot":-1,"title":"Stock Track | Galapagos NV Plunges 8% After Q2 Earnings Miss and Widened Losses","media":"Stock Track","content":"<p>Shares of Galapagos NV (GLPG) tumbled 8.02% in Thursday's trading session following the release of its disappointing second-quarter 2025 financial results. The biotechnology company reported a significant loss that fell well short of analyst expectations, causing investor concern.</p>\n\n<p>Galapagos posted a quarterly adjusted loss of €1.60 per share for the quarter ended June 30, a stark contrast to the €0.14 earnings per share reported in the same quarter last year. This result significantly missed the mean expectation of six analysts, who had forecast a loss of €0.20 per share. Revenue also declined by 16.2% to €65.29 million, falling short of the €70.60 million analysts had anticipated.</p>\n\n<p>The company's financial struggles were further highlighted in its half-year results, with Galapagos reporting a loss of €3.93 per diluted share for the first six months of 2025, compared to a profit of €1.51 per share in the same period last year. Despite these challenges, half-year revenue remained unchanged at €140.3 million. The stark reversal in profitability and the revenue decline in Q2 have raised concerns about the company's near-term prospects, leading to the sharp sell-off in its stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Galapagos NV Plunges 8% After Q2 Earnings Miss and Widened Losses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Galapagos NV Plunges 8% After Q2 Earnings Miss and Widened Losses\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-07-24 15:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Galapagos NV (GLPG) tumbled 8.02% in Thursday's trading session following the release of its disappointing second-quarter 2025 financial results. The biotechnology company reported a significant loss that fell well short of analyst expectations, causing investor concern.</p>\n\n<p>Galapagos posted a quarterly adjusted loss of €1.60 per share for the quarter ended June 30, a stark contrast to the €0.14 earnings per share reported in the same quarter last year. This result significantly missed the mean expectation of six analysts, who had forecast a loss of €0.20 per share. Revenue also declined by 16.2% to €65.29 million, falling short of the €70.60 million analysts had anticipated.</p>\n\n<p>The company's financial struggles were further highlighted in its half-year results, with Galapagos reporting a loss of €3.93 per diluted share for the first six months of 2025, compared to a profit of €1.51 per share in the same period last year. Despite these challenges, half-year revenue remained unchanged at €140.3 million. The stark reversal in profitability and the revenue decline in Q2 have raised concerns about the company's near-term prospects, leading to the sharp sell-off in its stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GLPG","symbol_name":"Galapagos NV","start_time":0,"source_url":"","article_id":"1104428000","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104428000","pubTimestamp":1753340553,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Galapagos NV (GLPG) tumbled 8.02% in Thursday's trading session following the release of its disappointing second-quarter 2025 financial results. The biotechnology company reported a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GLPG":"Galapagos NV"},"translate_title":"个股追踪|Galapagos NV在Q2盈利未达预期且亏损扩大后暴跌8%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLPG":1},"content_text":"Shares of Galapagos NV (GLPG) tumbled 8.02% in Thursday's trading session following the release of its disappointing second-quarter 2025 financial results. The biotechnology company reported a significant loss that fell well short of analyst expectations, causing investor concern.\nGalapagos posted a quarterly adjusted loss of €1.60 per share for the quarter ended June 30, a stark contrast to the €0.14 earnings per share reported in the same quarter last year. This result significantly missed the mean expectation of six analysts, who had forecast a loss of €0.20 per share. Revenue also declined by 16.2% to €65.29 million, falling short of the €70.60 million analysts had anticipated.\nThe company's financial struggles were further highlighted in its half-year results, with Galapagos reporting a loss of €3.93 per diluted share for the first six months of 2025, compared to a profit of €1.51 per share in the same period last year. Despite these challenges, half-year revenue remained unchanged at €140.3 million. The stark reversal in profitability and the revenue decline in Q2 have raised concerns about the company's near-term prospects, leading to the sharp sell-off in its stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104428000","isCrawlerRequest":true}